Inventor · disambiguated record
Hirokazu Annoura
Also filed as: ANNOURA HIROKAZU
18 granted patents·2 pending applications·213 citations·filing 1995–2010
94Inventor score
Files withSUNTORY LTD10ASUBIO PHARMA CO LTD3DAIICHI ASUBIO PHARMA CO LTD2DAIICHI SUNTORY PHARMA CO LTD2JAPAN GOVERNMENT2
Top patents by PatentIndex Score
20 records- 0190US7732583B2Glycolipids and synthetic method thereof as well as their synthetic intermediates, and synthetic intermediates, and synthetic method thereofJAPAN GOVERNMENT·Filed 2004·Granted Jun 8, 2010·36 cites·4 claims
- 0282US6998401B2Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereofSUNTORY LTD·Filed 2003·Granted Feb 14, 2006·13 cites·6 claims
- 0378US6838470B2Arylpiperidinopropanol and arylpiprazinopropanol derivatives and pharmaceuticals containing the sameDAIICHI SUNTORY PHARMA CO LTD·Filed 2002·Granted Jan 4, 2005·9 cites·14 claims
- 0477US5621099ASynthetic method of hymenialdisine and its derivatives and their synthetic intermediates, and those synthetic intermediatesSUNTORY LTD·Filed 1995·Granted Apr 15, 1997·23 cites·5 claims
- 0574US6048876AMedicament for the alleviation or treatment of symptom derived from ischemic disease and compound useful thereforSUNTORY LTD·Filed 1996·Granted Apr 11, 2000·38 cites·31 claims
- 0673US6706734B2Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the sameDAIICHI SUNTORY PHARMA CO LTD·Filed 2002·Granted Mar 16, 2004·5 cites·9 claims
- 0772US6559146B1Aminophenoxyacetic acid derivatives as neuroprotectantsSUNTORY LTD·Filed 1999·Granted May 6, 2003·26 cites·25 claims
- 0869US6525199B1Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the sameSUNTORY LTD·Filed 2002·Granted Feb 25, 2003·3 cites·1 claims
- 0964US7642262B2Arylipiperdinopropanol and arylipiperazinopropanol derivatives and pharmaceuticals containing the sameASUBIO PHARMA CO LTD·Filed 2004·Granted Jan 5, 2010·1 cites·7 claims
- 1064US5843988ACyclopropachromencarboxylic acid derivativesSUNTORY LTD·Filed 1995·Granted Dec 1, 1998·26 cites·5 claims
- 1163US6469010B1Medicament for the alleviation or treatment of symptom derived from the ischemic disease and compound useful thereofSUNTORY LTD·Filed 2000·Granted Oct 22, 2002·2 cites·22 claims
- 1262US7067533B2Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereofDAIICHI ASUBIO PHARMA CO LTD·Filed 2001·Granted Jun 27, 2006·2 cites·8 claims
- 1358US6455549B1Arylpiperidinol and arylpiperidine derivatives and drugs containing the sameSUNTORY LTD·Filed 1997·Granted Sep 24, 2002·12 cites·12 claims
- 1458US5723475AArylpiperidine and arylpiperazine derivatives and medicament containing the sameSUNTORY LTD·Filed 1996·Granted Mar 3, 1998·8 cites·13 claims
- 1557US7488738B2Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereofASUBIO PHARMA CO LTD·Filed 2005·Granted Feb 10, 2009·0 cites·6 claims
- 1655US7498344B2Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the sameASUBIO PHARMA CO LTD·Filed 2004·Granted Mar 3, 2009·0 cites·6 claims
- 1755US6407099B1Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the sameSUNTORY LTD·Filed 1998·Granted Jun 18, 2002·9 cites·10 claims
- 1850US8034908B2Glycolipids and synthetic method thereof as well as their synthetic intermediates, and synthetic method thereofJAPAN GOVERNMENT·Filed 2010·Granted Oct 11, 2011·0 cites·13 claims
- 1948US2006178401A1Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereofDAIICHI ASUBIO PHARMA CO LTD·Filed 2006·Application pending·0 cites
- 2042US2009048185A1Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active IngredientMIYAKE SACHIKO·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hirokazu Annoura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →